199 related articles for article (PubMed ID: 16782831)
1. Lessons from structure-function studies in asthma: myths and truths about what we teach.
Irvin CG
J Appl Physiol (1985); 2006 Jul; 101(1):7-9. PubMed ID: 16782831
[No Abstract] [Full Text] [Related]
2. The structural basis of airways hyperresponsiveness in asthma.
Stănescu DC
J Appl Physiol (1985); 2006 Dec; 101(6):1812; author reply 1813. PubMed ID: 16931560
[No Abstract] [Full Text] [Related]
3. The structural basis of airways hyperresponsiveness in asthma.
Brown RH; Pearse DB; Pyrgos G; Liu MC; Togias A; Permutt S
J Appl Physiol (1985); 2006 Jul; 101(1):30-9. PubMed ID: 16469934
[TBL] [Abstract][Full Text] [Related]
4. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Belman MJ; Botnick WC; Shin JW
Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
[TBL] [Abstract][Full Text] [Related]
5. Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1.
Sterk PJ
Eur Respir J; 2004 Apr; 23(4):497-8. PubMed ID: 15083741
[No Abstract] [Full Text] [Related]
6. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
[TBL] [Abstract][Full Text] [Related]
7. Regional airflow obstruction after bronchoconstriction and subsequent bronchodilation in subjects without pulmonary disease.
Geier ET; Theilmann RJ; Prisk GK; Sá RC
J Appl Physiol (1985); 2019 Jul; 127(1):31-39. PubMed ID: 31120808
[TBL] [Abstract][Full Text] [Related]
8. Reversible airflow obstruction in lymphangioleiomyomatosis.
Taveira-DaSilva AM; Steagall WK; Rabel A; Hathaway O; Harari S; Cassandro R; Stylianou M; Moss J
Chest; 2009 Dec; 136(6):1596-1603. PubMed ID: 19447921
[TBL] [Abstract][Full Text] [Related]
9. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD.
O'Donnell DE; Sciurba F; Celli B; Mahler DA; Webb KA; Kalberg CJ; Knobil K
Chest; 2006 Sep; 130(3):647-56. PubMed ID: 16963658
[TBL] [Abstract][Full Text] [Related]
10. [Other forms of bronchodilation].
Izquierdo Alonso JL; Malo de Molina R
Arch Bronconeumol; 2004 Mar; 40 Suppl 1():23-9. PubMed ID: 16137446
[No Abstract] [Full Text] [Related]
11. Determinants of bronchodilator responsiveness in patients with controlled asthma.
Koga T; Kamimura T; Oshita Y; Narita Y; Mukaino T; Nishimura M; Mizoguchi Y; Aizawa H
J Asthma; 2006; 43(1):71-4. PubMed ID: 16448969
[TBL] [Abstract][Full Text] [Related]
12. Determining the time to maximal bronchodilator response in asthmatic children.
Stavreska V; Verheggen M; Oostryck J; Stick SM; Hall GL
J Asthma; 2009 Feb; 46(1):25-9. PubMed ID: 19191133
[TBL] [Abstract][Full Text] [Related]
13. The role of methotrexate in the management of steroid-dependent asthma.
Coffey MJ; Sanders G; Eschenbacher WL; Tsien A; Ramesh S; Weber RW; Toews GB; McCune WJ
Chest; 1994 Jan; 105(1):117-21. PubMed ID: 7903921
[TBL] [Abstract][Full Text] [Related]
14. Dependence of bronchoconstrictor and bronchodilator responses on thoracic gas compression volume.
Pellegrino R; Antonelli A; Crimi E; Gulotta C; Torchio R; Dutto L; Pedersen OF; Brusasco V
Respirology; 2014 Oct; 19(7):1040-5. PubMed ID: 25039769
[TBL] [Abstract][Full Text] [Related]
15. Aging does not affect beta-agonist responsiveness after methacholine-induced bronchoconstriction.
Parker AL
J Am Geriatr Soc; 2004 Mar; 52(3):388-92. PubMed ID: 14962153
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of outdoor air pollutants are associated with reduced bronchodilation in children with asthma.
Hernández-Cadena L; Holguin F; Barraza-Villarreal A; Del Río-Navarro BE; Sienra-Monge JJ; Romieu I
Chest; 2009 Dec; 136(6):1529-1536. PubMed ID: 19318670
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of paradoxical bronchoconstriction after inhaled albuterol.
Schissler AJ; Celli BR
Respir Med; 2018 Aug; 141():100-102. PubMed ID: 30053954
[TBL] [Abstract][Full Text] [Related]
18. Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD.
Berton DC; Barbosa PB; Takara LS; Chiappa GR; Siqueira AC; Bravo DM; Ferreira LF; Neder JA
Thorax; 2010 Jul; 65(7):588-93. PubMed ID: 20627914
[TBL] [Abstract][Full Text] [Related]
19. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol.
Ind PW
Br J Hosp Med; 1990 Nov; 44(5):343-4. PubMed ID: 1980426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
